You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聖濟堂(600227.SH):擬對控股子公司中觀生物增資6600萬元
格隆匯 03-21 15:43

格隆匯3月21日丨聖濟堂(600227.SH)公吿稱,貴州中觀生物技術有限公司(簡稱“中觀生物”)是公司於2018年收購的的控股子公司。當前註冊資本為1250.00萬元人民幣,其中公司以貨幣出資持股80%,HE XIAOQING以技術作價持股20%。

為支持中觀生物的幹細胞新藥研發項目正常推進,優化中觀生物的財務結構,為中觀生物下一步發展提供便利條件,公司擬對中觀生物以現金方式增資6600.00萬元,中觀生物另一股東HE XIAOQING將根據其原持股比例(即持股20%)對中觀生物認繳出資。

增資完成後,雙方股東持股比例不變,中觀生物仍是公司的控股子公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account